Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2017

29.08.2016 | Thoracic Oncology

Proximal Resection Margin in Ivor-Lewis Oesophagectomy for Cancer

verfasst von: Y. A. Qureshi, MBBS, MRCS, MSc, FRCS, S.-J. Sarker, MSc(Stat), MSc(Epid), PhD, PGCAP, R. C. Walker, MBChB, MRCS, S. F. Hughes, MS, FRCS

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

The purpose of this study was to investigate whether a long proximal oesophageal resection margin (PRM) is associated with improved survival after oesophagectomy for cancer and to identify the optimal margin to aim for in this patient group.

Methods

A prospectively maintained database identified 174 patients who underwent Ivor-Lewis oesophagectomy for cancer. Demographic, clinical, and pathological data were collected. X-tile software was used to identify the optimal resection point. Two models were analysed: single point resection with comparison of two groups (short and long), and two resection points with three groups (short, medium, and long) to provide a range.

Results

The median PRM was 4.0 cm (interquartile range: 2.5–6.0 cm). After adjustment for significant confounders, multivariable Cox PH analysis demonstrated that the optimal resection margin was 1.7 cm, and in the three-group analysis the optimum PRM was between 1.7 and 3 cm. In the two-group analysis, the long margin had no effect on DFS (p = 0.37), but carried a significantly improved overall survival (hazard ratio [HR] = 0.46, 95 % confidence interval [CI] 0.25–0.87, p = 0.02). In the three-group analysis, the medium and long groups had improved OS compared with the short group (on average 54 %, HR ≥ 0.45, p ≤ 0.04). The 5-year disease-free and overall survival rates were highest in the medium PRM group (48 and 57 % respectively).

Conclusions

Optimal survival following oesophagectomy for cancer is achieved with a PRM > 1.7 cm, but a PRM > 3 cm does not yield a further survival advantage. Thus, the optimal PRM is likely to be between 1.7 and 3 cm.
Literatur
1.
Zurück zum Zitat DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol. 2006;13:12–30.CrossRefPubMed DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol. 2006;13:12–30.CrossRefPubMed
2.
Zurück zum Zitat Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–53.CrossRefPubMed Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–53.CrossRefPubMed
3.
Zurück zum Zitat Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal Carcinoma. Lancet. 2013;381:400–12.CrossRefPubMed Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal Carcinoma. Lancet. 2013;381:400–12.CrossRefPubMed
4.
Zurück zum Zitat Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128–37.CrossRefPubMed Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128–37.CrossRefPubMed
5.
Zurück zum Zitat Siewert JR, Holscher AH, Dittler HJ. Preoperative staging and risk analysis in esophageal carcinoma. Hepato-gastroenterol. 1990;37:382–7. Siewert JR, Holscher AH, Dittler HJ. Preoperative staging and risk analysis in esophageal carcinoma. Hepato-gastroenterol. 1990;37:382–7.
6.
Zurück zum Zitat Ellis FH, Heatley GJ, Krasna MJ, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg. 1997;113:836–48.CrossRefPubMed Ellis FH, Heatley GJ, Krasna MJ, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg. 1997;113:836–48.CrossRefPubMed
7.
Zurück zum Zitat Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 2007;246:1–8.CrossRefPubMedPubMedCentral Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 2007;246:1–8.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Sagar PM, Johnston D, McMahon MJ, Dixon MF, Quirke P. Significance of circumferential resection margin involvement after esophagectomy for cancer. Br J Surg. 1993;80:1386–8.CrossRefPubMed Sagar PM, Johnston D, McMahon MJ, Dixon MF, Quirke P. Significance of circumferential resection margin involvement after esophagectomy for cancer. Br J Surg. 1993;80:1386–8.CrossRefPubMed
9.
Zurück zum Zitat O’Neill JR, Stephens NA, Save V, et al. Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment. Br J Surg. 2013;100(8):1055–63.CrossRefPubMed O’Neill JR, Stephens NA, Save V, et al. Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment. Br J Surg. 2013;100(8):1055–63.CrossRefPubMed
10.
Zurück zum Zitat Miller C. Carcinoma of the thoracic esophagus and cardia. A review of 405 cases. Br J Surg. 1962;49:507–22.CrossRefPubMed Miller C. Carcinoma of the thoracic esophagus and cardia. A review of 405 cases. Br J Surg. 1962;49:507–22.CrossRefPubMed
11.
Zurück zum Zitat Skinner DB. En Bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg. 1983;85:59–71.PubMed Skinner DB. En Bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg. 1983;85:59–71.PubMed
12.
Zurück zum Zitat Tsutsui S, Kuano H, Watanabe M, Kitamura M, Sugimachi K. Resection margin for squamous cell carcinoma of the esophagus. Ann Surg. 1995;222:193–202.CrossRefPubMedPubMedCentral Tsutsui S, Kuano H, Watanabe M, Kitamura M, Sugimachi K. Resection margin for squamous cell carcinoma of the esophagus. Ann Surg. 1995;222:193–202.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Law S, Arcilla C, Chu K, Wong J. The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg. 1998;176:286–90.CrossRefPubMed Law S, Arcilla C, Chu K, Wong J. The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg. 1998;176:286–90.CrossRefPubMed
14.
Zurück zum Zitat Earlam R, Cunha-Melo JR. Esophageal squamous cell carcinoma: a critical review of surgery. Br J Surg. 1980; 67: 381–90.CrossRefPubMed Earlam R, Cunha-Melo JR. Esophageal squamous cell carcinoma: a critical review of surgery. Br J Surg. 1980; 67: 381–90.CrossRefPubMed
15.
Zurück zum Zitat Sugimachi K, Inokuchi K, Kuano H, et al. Patterns of recurrence after curative resection for carcinoma of the thoracic part of the esophagus. Surg Gynecol Obstet. 1983;157:537–40.PubMed Sugimachi K, Inokuchi K, Kuano H, et al. Patterns of recurrence after curative resection for carcinoma of the thoracic part of the esophagus. Surg Gynecol Obstet. 1983;157:537–40.PubMed
16.
Zurück zum Zitat Biere SS, Maas KW, Cuesta MA, van der Peet DL. Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg. 2011;28:29–35.CrossRefPubMed Biere SS, Maas KW, Cuesta MA, van der Peet DL. Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg. 2011;28:29–35.CrossRefPubMed
17.
Zurück zum Zitat Chang AC, Ji H, Birkmeyer NJ, Orringer MB, Birkmeyer JD. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg. 2008;85:424–9.CrossRefPubMed Chang AC, Ji H, Birkmeyer NJ, Orringer MB, Birkmeyer JD. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg. 2008;85:424–9.CrossRefPubMed
18.
Zurück zum Zitat Kassis ES, Kosinski AS, Ross P, Koppes KE, Donahue JM, Daniel VC. Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg. 2013;96:1919–26.CrossRefPubMed Kassis ES, Kosinski AS, Ross P, Koppes KE, Donahue JM, Daniel VC. Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg. 2013;96:1919–26.CrossRefPubMed
19.
Zurück zum Zitat Siewert JR, Stein HJ. Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esoph. 1996;9:173–82. Siewert JR, Stein HJ. Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esoph. 1996;9:173–82.
20.
Zurück zum Zitat Sobin LH, Wittekind C. TNM classification of malignant tumours. 6 edn. Hoboken: John Wiley & Sons; 2002. Sobin LH, Wittekind C. TNM classification of malignant tumours. 6 edn. Hoboken: John Wiley & Sons; 2002.
21.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C (eds). TNM classification of malignant tumours, 7th edn. Chichester: Wiley-Blackwell; 2009. Sobin LH, Gospodarowicz MK, Wittekind C (eds). TNM classification of malignant tumours, 7th edn. Chichester: Wiley-Blackwell; 2009.
22.
Zurück zum Zitat Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Statist Assn. 1958;53(282):457–81.CrossRef Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Statist Assn. 1958;53(282):457–81.CrossRef
23.
Zurück zum Zitat Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–9.CrossRefPubMed Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–9.CrossRefPubMed
24.
Zurück zum Zitat Portale G, Hagen JA, Peters JH, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg. 2006;202(4):588–96.CrossRefPubMed Portale G, Hagen JA, Peters JH, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg. 2006;202(4):588–96.CrossRefPubMed
25.
Zurück zum Zitat Koyanagi K, Igaki H, Iwabu J, Ochiai H, Tachimori Y. Recurrent laryngeal nerve paralysis after esophagectomy: respiratory complications and role of nerve reconstruction. Tohoku J Exp Med. 2015;237(1):1–8.CrossRefPubMed Koyanagi K, Igaki H, Iwabu J, Ochiai H, Tachimori Y. Recurrent laryngeal nerve paralysis after esophagectomy: respiratory complications and role of nerve reconstruction. Tohoku J Exp Med. 2015;237(1):1–8.CrossRefPubMed
26.
Zurück zum Zitat Kfir B-D, Fullerton A, Rossidis G, et al. Prospective comprehensive swallowing evaluation of minimally invasive esophagectomies with cervical anastomosis: silent versus vocal aspiration. J Gastrointest Surg. 2015;19(10):1748–52.CrossRef Kfir B-D, Fullerton A, Rossidis G, et al. Prospective comprehensive swallowing evaluation of minimally invasive esophagectomies with cervical anastomosis: silent versus vocal aspiration. J Gastrointest Surg. 2015;19(10):1748–52.CrossRef
27.
Zurück zum Zitat Matthews HR, Steel A. Left-sided subtotal oesophagectomy for carcinoma. Br J Surg. 1987;74:1115–7.CrossRefPubMed Matthews HR, Steel A. Left-sided subtotal oesophagectomy for carcinoma. Br J Surg. 1987;74:1115–7.CrossRefPubMed
28.
Zurück zum Zitat Wong J. Esophageal resection for cancer: the rationale of current practice. Am J Surg. 1987:163;18–24.CrossRef Wong J. Esophageal resection for cancer: the rationale of current practice. Am J Surg. 1987:163;18–24.CrossRef
29.
30.
Zurück zum Zitat Turkyilmaz A, Eroglu A, Aydin Y, Tekinbas C, Erol MM, Karaoglanoglu N. The management of esophagogastric anastomotic leak after esophagectomy for esophageal carcinoma. Dis Esophagus. 2009;22(2):119–26.CrossRefPubMed Turkyilmaz A, Eroglu A, Aydin Y, Tekinbas C, Erol MM, Karaoglanoglu N. The management of esophagogastric anastomotic leak after esophagectomy for esophageal carcinoma. Dis Esophagus. 2009;22(2):119–26.CrossRefPubMed
31.
Zurück zum Zitat Luketich JD, Alvelo-Rivera M, Buenacentura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486–94.PubMedPubMedCentral Luketich JD, Alvelo-Rivera M, Buenacentura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486–94.PubMedPubMedCentral
32.
Zurück zum Zitat Huang L, Onaitis M. Minimally invasive and robotic Ivor Lewis oesophagectomy. J Thorac Dis. 2014;6(3):314–21. Huang L, Onaitis M. Minimally invasive and robotic Ivor Lewis oesophagectomy. J Thorac Dis. 2014;6(3):314–21.
33.
Zurück zum Zitat Mariette C, Castel B, Balon JM, Van Seuningen I, Triboulet JP. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol. 2003;29(7):588–93.CrossRefPubMed Mariette C, Castel B, Balon JM, Van Seuningen I, Triboulet JP. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol. 2003;29(7):588–93.CrossRefPubMed
34.
Zurück zum Zitat Mine S, Sano T, Hiki N, et al. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg. 2013;100:1050–4.CrossRefPubMed Mine S, Sano T, Hiki N, et al. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg. 2013;100:1050–4.CrossRefPubMed
35.
Zurück zum Zitat Takubo K, Sasajima K, Yamashita K, Tanaka Y, Fujita K. Prognostic significance of intramural metastasis in patients with esophageal carcinoma. Cancer. 1990;65(8):1816-9.CrossRefPubMed Takubo K, Sasajima K, Yamashita K, Tanaka Y, Fujita K. Prognostic significance of intramural metastasis in patients with esophageal carcinoma. Cancer. 1990;65(8):1816-9.CrossRefPubMed
36.
Zurück zum Zitat Von Rahden BH, Stein HJ, Feith M, Becker K, Siewert JR. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction. J Clin Oncol. 2005;23:874–9.CrossRef Von Rahden BH, Stein HJ, Feith M, Becker K, Siewert JR. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction. J Clin Oncol. 2005;23:874–9.CrossRef
37.
Zurück zum Zitat van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98(3):547–57.CrossRefPubMedPubMedCentral van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98(3):547–57.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202–10.PubMed Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202–10.PubMed
39.
Zurück zum Zitat Akiyama H, Tsurumaru M, Watanabe G, et Al. Development of Surgery for carcinoma of the oesophagus. Am J Surg. 1984;147:9–16.CrossRefPubMed Akiyama H, Tsurumaru M, Watanabe G, et Al. Development of Surgery for carcinoma of the oesophagus. Am J Surg. 1984;147:9–16.CrossRefPubMed
40.
Zurück zum Zitat Mandard AM, Chasle J, Marnay J, et al. Autopsy findings in 111 cases of oesophageal cancer. Cancer. 1981;48:329–35.CrossRefPubMed Mandard AM, Chasle J, Marnay J, et al. Autopsy findings in 111 cases of oesophageal cancer. Cancer. 1981;48:329–35.CrossRefPubMed
41.
Zurück zum Zitat Sons HU, Bouchard F. Cancer of the distal oesophagus and cardia. Incidence, tumourous infiltration and metastatic spread. Ann Surg. 1986;203:188–95.CrossRefPubMedPubMedCentral Sons HU, Bouchard F. Cancer of the distal oesophagus and cardia. Incidence, tumourous infiltration and metastatic spread. Ann Surg. 1986;203:188–95.CrossRefPubMedPubMedCentral
Metadaten
Titel
Proximal Resection Margin in Ivor-Lewis Oesophagectomy for Cancer
verfasst von
Y. A. Qureshi, MBBS, MRCS, MSc, FRCS
S.-J. Sarker, MSc(Stat), MSc(Epid), PhD, PGCAP
R. C. Walker, MBChB, MRCS
S. F. Hughes, MS, FRCS
Publikationsdatum
29.08.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2017
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5510-y

Weitere Artikel der Ausgabe 2/2017

Annals of Surgical Oncology 2/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.